Similarly to the patterns of expression of mitotic kinases in breast cancers that do not fall under traditional classification (or that failed to classify) FOXM1, E2F1, E2F2, E2F3, and c-Myc are overexpressed in that subtype. This evidence concerns the gene MYC and breast cancer.